Clinical Trials Browser

Interventional × Melanoma × B3(Fv)-PE38KDEL recombinant immunotoxin × Clear all

NCT00295958 2012-06-14

LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

Melanoma, Skin Neoplasms